Ten patients with advanced or refractory CD5-expressing hematologic neoplasms [two with chronic lymphocytic leukemia and eight with cutaneous T-cell lymphoma (CTCL)] were treated in a Phase I study with the radioimmunoconjugate 90Y-T101, which targets CD5+ lymphocytes. Prior imaging studies using 111In-T101 demonstrated uptake in involved lymph nodes and skin in patients with CTCL, and Phase I ...

Selective internal radiation therapy has emerged as a well-accepted therapeutic for primary and metastatic hepatic malignancies. This therapeutic modality requires the combined efforts of multiple medical disciplines to ensure the safe delivery of yttrium-90 (90Y)-labeled microspheres. The development of this therapy followed decades of clinical research involving tumor vascularity and microsph...

ةصلاخلا Allopeas gracilis is recorded for the first time in southern Iraq. It was collected from two localities (Abu-Al Khaseeb region and Hareer region) from Basrah city. ضرلاا عقوقلا نم ةنيع نورشعو نامث ي Allopeas gracilis مت للاخ ةرصبلا ةنيدم ،ريرح ةقطنم و بيصخلا وبا ةقطنم نم اھعمج ناسين رھش 2008 راذاو 2008 يلاوتلا ىلع . ليجستلا اذھ ربتعي دعب ةرصبلا ةنيدم نم ةيضرلاا عقاوقلا نم ثلاثلا Monacha...

in this scientific research, for the first time, the removal of radioactive strontium-90 (90sr) by γ-mno2-aga zeolite as a novel nanocomposite adsorbent was accomplished under different conditions such as ph, temperature, adsorbent amount and the contact time that are examined from drinking water of ramsar city and monitored via ultra low-level liquid scintillation counting (lsc) technique. pri...

The application of ionizing radiations in different fields requires the use of equipment capable of detecting their presence or quantifying them. Detectors of the most different shapes, composition and characteristics are required to cover the full range of application of ionizing radiations. At present, thermoluminescent detectors (TLD) are the most widely employed for individual gamma monitor...

A 65 year old male with metastatic colorectal cancer (mCRC) in the liver was referred for selective internal radionuclide therapy (SIRT) following a history of extensive systemic chemotherapy. 90Y PET imaging was performed immediately after treatment and used to confirm lesion targeting and measure individual lesion absorbed doses. Lesion dosimetry was highly predictive of eventual response in ...

Radioembolization (RE) with glass microspheres (MS) loaded Yttrium-90 (90Y) has been used to treat tumors in the liver some reported success. However, assessing absorbed doses (AD) planning tumor volume (PTV) and normal (NLV) is a key problem address RE. In clinical practice, computation of 90Y activity be administered follows manufacturer’s recommendations, which do not consider specific chara...

INTRODUCTION Yttrium 90-ibritumomab tiuxetan (90Y-IT) radioimmunotherapy has proved to be effective in relapsed follicular lymphoma (FL). We conducted a clinical trial in which 90Y-IT followed by maintenance rituximab (MR) was evaluated as initial therapy for high-tumor-burden FL. METHODS Eligible patients had histologically confirmed FL and met the GELF (Groupe d'Etude des Lymphomes Follicul...